Dyslipidemia and Risk of Cardiovascular Events in Patients With Atrial Fibrillation Treated With Oral Anticoagulation Therapy: Insights From the ARISTOTLE (Apixaban for Reduction in Stroke and Other Thromboembolic Events in Atrial Fibrillation) Trial.
J Am Heart Assoc
; 7(3)2018 02 01.
Article
en En
| MEDLINE
| ID: mdl-29419390
Palabras clave
Texto completo:
1
Bases de datos:
MEDLINE
Asunto principal:
Pirazoles
/
Piridonas
/
Fibrilación Atrial
/
Tromboembolia
/
Apolipoproteína A-I
/
Accidente Cerebrovascular
/
Dislipidemias
/
Apolipoproteína B-100
/
Inhibidores del Factor Xa
Tipo de estudio:
Clinical_trials
/
Diagnostic_studies
/
Etiology_studies
/
Observational_studies
/
Prognostic_studies
/
Risk_factors_studies
Límite:
Aged
/
Female
/
Humans
/
Male
/
Middle aged
Idioma:
En
Revista:
J Am Heart Assoc
Año:
2018
Tipo del documento:
Article
País de afiliación:
Suecia